G2A is a heptahelical cell surface protein that has recently been described as a potential tumor suppressor, based on its ability to counteract transformation of pre-B cells and ®broblasts by Bcr-Abl, an oncogenic tyrosine kinase. We have isolated cDNAs encoding G2A in the course of screening libraries for clones that cause oncogenic transformation of NIH3T3 ®broblasts. When expressed at high levels in NIH3T3 cells by retroviral transduction, G2A induced a full range of phenotypes characteristic of oncogenic transformation, including loss of contact inhibition, anchorage-independent survival and proliferation, reduced dependence on serum, and tumorigenicity in mice. When expressed by transfection, G2A greatly enhanced the ability of a weakly oncogenic form of Raf-1 to transform NIH3T3 cells. These results demonstrate that G2A is potently oncogenic both on its own and in cooperation with another oncogene. Expression of G2A in ®broblasts and endothelial cells resulted in changes in cell morphology and cytoskeleton structure that were equivalent to those induced by the G protein subunit Ga 13 . Transformation of NIH3T3 cells via G2A expression was completely suppressed by co-expression of LscRGS, a GTPase activating protein that suppresses signaling by Ga 12 and Ga 13 . Hyperactivity of Ga 12 or Ga 13 has previously been shown to result in activation of Rho GTPases. G2A expression resulted in activation of Rho, and transformation via G2A was suppressed by a dominant negative form of RhoA. These results indicate that G2A may be directly coupled to Ga 13 , and that it is the activation of this Rho-activating Ga protein which is responsible for the ability of G2A to transform ®bro-blasts.
G2A is a heptahelical cell surface protein that has recently been described as a potential tumor suppressor, based on its ability to counteract transformation of pre-B cells and ®broblasts by Bcr-Abl, an oncogenic tyrosine kinase. We have isolated cDNAs encoding G2A in the course of screening libraries for clones that cause oncogenic transformation of NIH3T3 ®broblasts. When expressed at high levels in NIH3T3 cells by retroviral transduction, G2A induced a full range of phenotypes characteristic of oncogenic transformation, including loss of contact inhibition, anchorage-independent survival and proliferation, reduced dependence on serum, and tumorigenicity in mice. When expressed by transfection, G2A greatly enhanced the ability of a weakly oncogenic form of Raf-1 to transform NIH3T3 cells. These results demonstrate that G2A is potently oncogenic both on its own and in cooperation with another oncogene. Expression of G2A in ®broblasts and endothelial cells resulted in changes in cell morphology and cytoskeleton structure that were equivalent to those induced by the G protein subunit Ga 13 . Transformation of NIH3T3 cells via G2A expression was completely suppressed by co-expression of LscRGS, a GTPase activating protein that suppresses signaling by Ga 12 and Ga 13 . Hyperactivity of Ga 12 orIntroduction G protein-coupled receptors (GPCRs) provide a means of communication between the environment and the interior of a cell by interacting with speci®c ligands and then triggering signaling via associated heterotrimeric G proteins (Dhanasekaran et al., 1998; Strader et al., 1995) . The nature of the signals initiated by a GPCR depend on the speci®c composition of a, b and g subunits of the G proteins to which it couples, as well as the presence or absence of speci®c eectors or regulators of those subunits. Most GPCRs stimulate or suppress specialized functions in dierentiated cells. However, some GPCRs can also regulate cell proliferation, and aberrant GPCR expression can contribute to oncogenesis . Expression cloning of mas as a gene that encodes a transforming protein provided the ®rst indication that this class of cell surface receptors could function as oncoproteins (Young et al., 1988) . Subsequently, other GPCRs have been shown to have oncogenic properties. These include the M1-, M3-and M5-muscarinic acetylcholine receptors (Gutkind et al., 1991) , the serotonin 1c receptor (Julius et al., 1989) , the a 1B -adrenergic receptor (Allen et al., 1991) and the thrombin receptor (Whitehead et al., 1995) , as well as a viral GPCR (Bais et al., 1998) . However, the large majority of GPCRs are not oncogenic. Constitutively activated mutants of the G protein a subunits Ga i2 , Ga q , Ga 12 , and Ga 13 (De Vivo et al., 1992; Jiang et al., 1993; Pace et al., 1991; Vara Prasad et al., 1994; Voyno-Yasenetskaya et al., 1994; Xu et al., 1993) , and even wild-type forms of Ga 12 and Ga 13 (Chan et al., 1993) (our unpublished results) also show transforming activity in rodent ®broblasts, suggesting that these a subunits alone can transmit signals leading to transformation, with no requirement for bg subunit signaling.
One common feature shared by the oncogenic GPCRs and Ga q , Ga 12 , and Ga 13 subunits is their abilities to activate Rho or Rac GTPases (Buhl et al., 1995; Collins et al., 1996; Fromm et al., 1997; Gohla et al., 1998; Hooley et al., 1996; Katoh et al., 1998; Mao et al., 1998b; Seasholtz et al., 1999; Zohn et al., 1998a) . Rho, Rac and related GTPases can contribute to ®broblast transformation by stimulating mitogenesis, suppressing contact inhibition of proliferation, and overriding the requirement for cell-substrate contact (Zohn et al., 1998b) . Rho family members can also induce radical changes in the structure of the cytoskeleton. In Swiss 3T3 ®broblasts, RhoA causes stress ®ber and focal adhesion formation, whereas Rac1 causes lamellipodia formation and membrane ruing, as well as inducing stress ®bers and focal adhesions by activating Rho . In other cell types, the speci®c changes in the cytoskeleton can vary, but are still distinctive for speci®c Rho family members. Similarly, dierent Rho family members have their own distinct pattern of activation of speci®c kinases, lipases and transcription factors. For example, Rho activates a diverse set of kinases that directly or indirectly regulate cytoskeletal proteins, while Rac and CDC42 activate PAK or MLK family kinases and by this and other means cause the activation of JNK and p38 members of the MAP kinase family (Zohn et al., 1998b) . Rho activation can be induced by Rac, and Rac in turn can be indirectly activated via the small GTPase Ras . Rho can also be activated by expression of the G protein subunits Ga q , Ga 12 or Ga 13 (Buhl et al., 1995; Fromm et al., 1997) . These cascades of activation of GTPases are presumably regulated by the ability of one GTPase to directly or indirectly stimulate an activator of the next GTPase in the cascade, e.g. Ras indirectly stimulating the GTP exchange activity of Sos for Rac (Nimnual et al., 1998) , or Ga 13 directly stimulating the GTP exchange activity of Lsc/p115 RhoGEF for Rho . Therefore, a downstream GTPase such as Rho can be activated by a variety of pathways, with varying dependencies on other GTPases.
It is becoming apparent that GPCRs can activate Rho by a diversity of mechanisms Hall et al., 1999; Seasholtz et al., 1999) . These can involve coupling to either Ga q , Ga 13 or Ga 12 (Gohla et al., 1998 (Gohla et al., , 1999 Katoh et al., 1998; Mao et al., 1998b) . Gbg subunits may also provide a route to Rho activation, via Ras activation (Chen et al., 1996; Lopez-Ilasaca et al., 1997; Mattingly and Macara, 1996) . Pathways between Ga protein subunits and Rho are for the most part mysterious, potentially involving activation of tyrosine kinases (Gohla et al., 1998; Katoh et al., 1998; Mao et al., 1998a) , protein kinase Cs (Katoh et al., 1998) , Rac (Zohn et al., 1998a) and/or Ras (Collins et al., 1996 (Collins et al., , 1997 . The exchange factor Lsc (also known as p115 RhoGEF) may serve as a fully de®ned link between some GPCRs and Rho, and it is directly activated by Ga 13 , and is itself a direct activator of Rho (Glaven et al., 1996; Hart et al., 1996 Hart et al., , 1998 Kozasa et al., 1998) . However, this is not the only route from GPCRs to Rho because Ga 12 or Ga q are required for Rho activation by some GPCRs (Gohla et al., 1998; Mao et al., 1998b) but these two Ga subunits do not activate Lsc . G2A has recently been described as a putative GPCR that suppresses the ability of the oncogene Bcr-Abl to transform ®broblasts and pro-B cells (Weng et al., 1998) . This, plus additional results indicating that G2A expression might impose a block in the cell cycle at G 2 following serum deprivation, implicated this GPCR as a potential tumor suppressor. Prior to the publication of these results on G2A, we fortuitously cloned G2A-encoding cDNAs as part of a screen of a retrovirally transduced cDNA library for clones which could transform NIH3T3 cells. We demonstrate in this report that G2A is potently oncogenic in ®broblasts.
The transformed phenotype of G2A-expressing cells closely resembles that induced by activated Ga 12 or Ga 13 , and transformation via G2A is suppressed by an RGS protein that inhibits Ga 12 or Ga 13 . G2A expression also stimulates Rho activation, and Rho contributes to G2A-mediated transformation.
Results and discussion
Selection of T cell hybridoma-derived cDNA clones which transform NIH3T3 cells
We utilized a cDNA library expression strategy to identify potential oncogenes expressed by the T28 murine T hybridoma cell line. A bacterial plasmid library of 4610 6 clones was constructed in the pCTV1 retroviral vector using T28 cell cDNA. The plasmid library was converted to retroviral form by transfection into the ecotropic packaging cell line BOSC 23, and then used to infect approximately 2610 6 NIH3T3 cells. PCR analyses indicated that approximately half of the NIH3T3 cells became infected with a single intact retroviral vector carrying one of the library cDNAs. The population of infected NIH3T3 cells was grown to con¯uence, and maintained for an additional 12 days. Approximately 25 independent transformed foci developed in the library-infected NIH3T3 cell cultures, while no foci developed in control NIH3T3 cell cultures, infected with an equivalent number of CTV1 viruses lacking cDNA inserts.
Proviral cDNAs from single foci of transformed cells were ampli®ed by PCR, cloned into the retroviral vector pCTV3, and tested for transforming activity by infection of NIH3T3 cells. cDNAs which were positive for transformation in this secondary screen were then characterized by 5' end sequencing. Three of the positive cDNA clones, TL37-3c1, TL37-5c1 and TL37-8c1, were structurally distinct but had overlapping sequence identities and thus were derived from the same gene. Complete sequencing showed that they encoded the same protein, which later proved to be identical to G2A. Infection of NIH3T3 cell cultures with either TL37-5c1, TL37-3c1 or TL37-8c1 cDNAs in CTV3 resulted in the development of transformed foci that covered the entire surface of the culture dish.
Efficiency of transformation via G2A alone and in cooperation with weakly oncogenic Raf-1 A form of G2A with a COOH-terminal GFP tag was used to determine the eciency with which G2A expression leads to cell transformation. Following retroviral transduction with this construct, NIH3T3 cells were plated at very low density to allow formation of discrete colonies. Of 18 GFP-positive colonies analysed, 14 had obviously transformed cell morphologies and formed dense foci. No transformed colonies arose from infections using GFP alone. Therefore, G2A is very ecient at inducing transformation of NIH3T3 cells when it is expressed at the high levels achieved by retroviral transduction. When G2A was inserted into the pZIP expression vector and transfected into NIH3T3 cells, a much lower frequency of focus formation was observed (Figure 1 ). This presumably re¯ects the 10 ± 100-fold lower expression levels that are achieved from transfected ZIP vectors versus retrovirally transduced CTV vectors (R Kay, unpublished results). We used the low penetrance of transformation via transfected G2A to test the eects of combining expression of G2A with a weakly transforming oncogene i.e. the Y340D mutant of Raf-1. A very strong cooperativity was seen between transfected G2A and Raf-1(Y340D) in their abilities to transform NIH3T3 cells (Figure 1 ). This was similar to but greater than the cooperativity that occurs between Raf-1(Y340D) and an activated form of RhoA ( Figure  1 ). Therefore, in this context G2A has a potent transformation-enhancing activity.
The G2A sequence indicates that it is a GPCR The TL37-5c1 cDNA sequence contains a complete open reading frame, extending from an ATG start codon at base 101 to a TAA stop codon at base 1247 (Figure 2 ). The encoded 382 amino acid sequence has all of the expected features of a GPCR (Strader et al., 1994) , including seven potential membrane spanning segments enriched in hydrophobic amino acids, an aspartatearginine-tyrosine (DRY) sequence immediately COOHterminal to the third putative membrane spanning segment, cysteines in the second and third extracellular loops and in the COOH-terminal tail, and a potential N-linked glycosylation site in the N-terminal extracellular segment. The GFP-tagged form of G2A was localized to the plasma membrane, as well as to the endoplasmic reticulum and Golgi (data not shown), as expected for a GPCR undergoing continuous expression.
Among GPCRs with known ligands, those with the closest sequence similarity to G2A are P2Y-purinergic receptors, uridine nucleotide receptors, and proteinaseactivated receptor 2, which have some regions of up to 40% amino acid identity with G2A (data not shown). However, the similarity between G2A and any of these receptors is not high enough to suggest that G2A might be activated by similar ligands or coupled to similar heterotrimeric G proteins (Bourne, 1997) .
The NH 2 -terminal part of G2A, upstream of the ®rst putative membrane spanning segment, is 39 amino acids long. The NH 2 -terminal region of the authentic G2A protein could be larger than this, because while the presumptive start codon is in an excellent sequence context for initiation of translation (CCACCATGA), there is no in-frame stop codon upstream. This raises the possibility that coding sequences extend further upstream in full-length G2A mRNAs. However, while primer extension and PCR ampli®cation of the T28 cDNA libraries identi®ed numerous other G2A cDNAs the longest of these only added an additional 14 nucleotides to the 5' sequence, without providing an inframe stop codon. Therefore, the available evidence points to initiation of translation occurring at the ®rst ATG codon present in the TL-37-5c1 sequence.
G2A is expressed predominantly in hemopoietic cell types G2A mRNAs were found in abundance in thymus and spleen, and at lower levels in bone marrow ( Figure 3a ). G2A transcripts were detected at only very low levels in lung and stomach, and were undetectable in brain, liver, kidney and muscle. Following upon this apparent speci®city of expression in hemopoietic cells, we examined G2A expression in cell lines derived from lymphoid, myeloid, erythroid or multipotent hemopoietic cell lines. Transcript levels were very high in all four T cell lines examined ( Figure 3b ). G2A was also expressed in most B lymphoid and myeloid lines, although typically at much lower levels than that found in the T cell lines. No G2A transcripts were detected in NIH3T3 cells.
G2A induces a fully transformed phenotype in NIH3T3 cells
In addition to their capacity to form dense foci in monolayer cultures (Figure 4 ), G2A-expressing NIH3T3 cells were distinguished from control cells by their abilities to proliferate in soft agar cultures, albeit with lower colony forming eciencies and smaller colony sizes than were seen for Ras-transformed cells ( Figure 5 ). G2A-expressing NIH3T3 cells were also able to proliferate in sub-optimal concentrations of serum ( Figure 6 ), and formed progressive tumors when inoculated into athymic nude mice (data not shown). Thus, G2A expression induces the development of a broad spectrum of transformed phenotypes, including loss of contact inhibition, survival and proliferation in the absence of anchorage or in reduced concentrations of growth factors, and tumor initiation in vivo. The number of foci per dish was quanti®ed following staining with 4% crystal violet as described in Materials and methods. The data are shown as means+standard error for triplicate plates and are representative of at least three separate experiments Figure 2 Structural features of G2A. The 382 amino acid peptide encoded by the TL37-5c1 cDNA is shown and residues corresponding to the seven presumptive transmembrane segments are underlined. Extracellular cysteines predicted to be involved in intramolecular bonding at residues 112 and 184, and the DRY motif at residues 136 ± 138, are indicated by lower case letters G2A and RhoA cause similar focus morphologies Our initial indication of the mechanism by which G2A causes transformation came from the appearance of transformed foci induced when transfected into NIH3T3 cells. In contrast to the highly refractile appearance of Ras-induced foci, those induced by G2A consisted of nonrefractile cells that grew as tightly packed, multi-layered populations. The appearance of the G2A-induced foci were similar to those induced by activated Rho (Figure 4 ), or by activators of Rho or Rac, e.g. the Rac-activating GPCR Mas or the Rhoactivating G protein subunit Ga 13 (Figure 4 ), or the Rho-activating exchange factor Lsc (not shown). This focus morphology suggested that G2A transformation may involve activation of either Rho or Rac. a b Figure 3 G2A transcripts are expressed in hematopoietic tissues and cell lines. Northern blots of total RNA from tissues of a 6 week old C57BL/6J mouse (a) or polyA or total RNA from the indicated murine cell lines (b) were probed with a 3' untranslated region probe speci®c to G2A. The numbers at the side indicate the positions of RNA size markers in kilobases. T28, R1.1, Yac1 and MBL-2 are T lymphoid-derived cell lines. NSF70, ABE8, WEHI231, A20 and Ba/F3 are B lymphoid-derived cell lines. B6SutA is a multipotent hemopoietic line, DA3 and 32D are myeloid, GM979 is erythroid, and P388 is lymphoid in origin and phenotypically macrophage-like Empty vector-transfected cells (Vector) were used as a negative control for these assays Activated RhoA or Rac1 cause distinct focus morphologies when co-expressed with activated Raf (Zohn et al., 1998a) . Foci formed by co-transfection of activated RhoA along with Raf(340D) resembled the transformed foci induced by activated Ras, being comprised of cells that were highly refractile and spindle-shaped (Figure 7 ). In contrast, co-expression of activated Rac or Mas along with Raf(340D) produced diuse foci which were moderately refractile and did not contain spindle-shaped cells. Co-expression of G2A with Raf(340D) produced foci that were very similar to those arising from RhoA plus Raf cotransfections, and distinct from those arising from Rac plus Raf or Mas plus Raf transfections (Figure 7 ). This indicated that G2A could be activating Rho without activating Rac.
G2A-induced cytoskeletal changes are equivalent to those induced by Ga 13 or Ga q but distinct from those induced by Ga 12 The results presented above indicated that G2A might be causing transformation of NIH3T3 cells by activating Rho. As outlined in the introduction, the Ga subunits that are known to activate Rho are Ga 12 , Ga 13 and Ga q . Expression of activated forms of Ga 12 or Ga 13 in NIH3T3 cells caused the formation of foci with morphologies that were similar to those induced by G2A or Rho activators such as Lsc (Figure 4 and data not shown). G2A and activated forms of Ga 12 or Ga 13 also caused equivalent changes in cytoskeleton structure in NIH3T3 cells, e.g. the formation of stress ®bers but not membrane rues (data not shown). In contrast to NIH3T3 cells, porcine aortic endothelial (PAE) cells show distinctive changes in cytoskeletal structure when they express activated forms of Ga 12 versus Ga 13 . Ga 12 induces the formation of both stress ®bers and lamellipodia whereas activated Ga 13 induces stress ®bers without concurrent lamellipodia formation (Figure 8 ). Expression of G2A in PAE cells induced stress ®bers but not lamellipodia (Figure 8 ). Expression of activated RhoA also caused stress ®ber formation without lamellipodia formation. These results indicate that in PAE cells G2A may be able to activate Ga 13 , and thus Rho, but is unable to activate Ga 12 . We found that activated Ga q also induced stress ®bers but not lamellipodia when expressed in PAE cells (Figure 8 ). However, expression of G2A in COS cells does not increase basal levels of IP 3 (data not shown), indicating that G2A is not able to couple to Ga q .
Transformation via G2A requires Ga 12 or Ga 13
The potential role of Ga 12 or Ga 13 in the transforming activity of G2A was investigated by expression of the N-terminal RGS domain of the Rho-speci®c exchange factor Lsc/p115RhoGEF, which speci®cally shuts o signaling through Ga 12 and Ga 13 by stimulating the intrinsic GTPase activities of these Ga subunits . This RGS domain has no eect on Ga q , Ga i1 , Ga z or Ga S . NIH3T3 cells infected with and transformed by the G2A/GFP-expressing virus were super-infected with a retrovirus expressing the RGS domain of Lsc. This resulted in complete reversion of the G2A-expressing Figure 6 G2A-transformed cells can grow in low serum. Mass populations of NIH3T3 cells stably transfected with either the empty pZIP ± NeoSV(x)1 vector, or encoding activated HRas(61L) or G2A were plated at a density of 10 3 cells per 60 mm dish. After 24 h, the growth medium was changed to DMEM supplemented with 0.5, 2 or 10% calf serum. Cultures were maintained for 2 weeks, then stained with 4% crystal violet to visualize cells (Figure 9 and Table 1 ). LscRGS expression also reverted the transformation of NIH3T3 cells that was induced by over-expression of wild-type Ga 12 or Ga 13 , while it had no eect on transformation induced by expression of GTPase-defective forms of Ga 12 or Ga 13 (Figure 9 ), as expected if it suppresses the functions of these GTPases by stimulating their GTPase activities. LscRGS coexpression had no eect on transformation induction via activated Ras or Raf, via the Rac-activating exchange factor Vav or the Rho-activating exchange factor Lsc, or via expression of the growth factor PDGF-b (Figure 9 and data not shown). These results demonstrate the high speci®city of the RGS domain of Lsc for suppressing only Ga 12 or Ga 13 -dependent transformation.
Inhibition of Rho, Rac or Ras activation suppresses transformation via G2A
Rho activation occurring downstream of Ga 13 or Ga 12 activation could be sucient to cause the complete transformation of NIH3T3 cells that results from G2A a b Figure 8 G2A causes similar changes as RhoA and Ga 13 in the organization of the actin cytoskeleton. PAE cells were microinjected with expression constructs encoding G2A or the indicated Ga subunits along with GFP, or with Myc epitope-tagged RhoA(14V) as described in Materials and methods. Cells were serum starved following injection and actin was stained with RITC-phalloidin. Microinjected cells were identi®ed by visualizing GFP expression or by staining with anti-Myc antiserum Figure 9 Suppression of G2A-mediated transformation by LscRGS. NIH3T3 cells were infected with a control retrovirus (Nil) or with a retrovirus expressing LscRGS. These cells were then infected with control retrovirus (Vector) or retroviruses encoding G2A and the other indicated oncogenic proteins. Representative regions of the cultures were photographed at 8 days following infection with the oncogene-expressing retroviruses Figure 10 and Table 2 ). (Figure 10 ). This is an additional indication that transformation via G2A may involve Ga 13 but not Ga 12 . RhoA(19N) had no or marginal eects on transformation via Ras, Vav or Lsc (Figure 10 ). Note that over-expressing of Lsc has the potential to override the dominant negative mechanism of RhoA(19N), which is expected to occur via sequestration of Rho-speci®c exchange factors. G2A-induced transformation was also suppressed by dominant negative forms of Rac1 and H-Ras (Rac1 (17N) and H-Ras(17N), Figure 10 and Table 2 ). Rac1(17N) and H-Ras(17N) also suppressed transformation via either wild-type or activated forms of Ga 12 and Ga 13 , and by the Rho-speci®c exchange factor Lsc ( Figure 10 and data not shown). There are two possible explanations for these results. The ®rst is that these Rho activators also activate Rac and Ras under the conditions used in these experiments, although the cytoskeletal structures of the G2A and Ga 12/13 -expressing cells indicates that this is not the case. The second explanation is that Rho activation is necessary for transformation via G2A and Ga 13 (and to a lesser extent via Ga 12 ), but transformation cannot be attained if the basal levels of Ras or Rac activation provided by growth factors in serum are suppressed. The spontaneous rate of transformation was strongly suppressed by expression of Rac1(17N) and H-Ras(17N) but not by RhoA(19N) ( Table 2) , and saturation densities were variably aected by the three dierent dominant negative GTPases (Figure 10 ), indicating that a variety of growth characteristics can be dierentially perturbed by the dominant negatives. These results point out the ambiguities inherent in using dominant negatives to de®ne signaling pathways contributing to a complex event such as cell transformation. Nonetheless, the results show that in terms of their sensitivities to transformation suppression by dominant negative forms of small GTPases, G2A is equivalent to Ga 13 and is distinct from Ga 12 or activators of Rac or Ras.
G2A induces Rho-dependent transcriptional activation of the serum response factor
The eects of G2A on cell morphology and cytoskeletal structure, and the sensitivity of G2A-mediated transformation to suppression by RhoA(19N), implies that G2A can initiate signals that lead to Rho activation, presumably via Ga 13 or perhaps Ga 12 . To further investigate the possibility that G2A causes activation of Rho, we determined if transient expression of G2A could induce activation of SRF, a transcription factor complex which can be activated downstream of RhoA (Hill et al., 1995) . For these experiments we used a reporter construct where luciferase expression was controlled by a minimal promoter containing recognition sites for the SRF. G2A expression caused activation of SRF, to an extent equivalent to expression of activated RhoA(63L) (Figure 11a ). As expected, since activated Ga 12 and Figure 10 , gave similar quantitative results in terms of the extent of suppression of G2A-mediated transformation by co-expression of the dominant negative forms of the three GTPases Ga 13 are activators of RhoA, they also caused activation of SRF, although to a lesser extent than G2A. Activated forms of Rac1 and Ras also induced SRF. Activation of SRF by G2A expression was partially inhibited by either RhoA(19N), or by C3, an ADP-ribosyltransferase which activates RhoA, RhoB and RhoC (Aktories and Hall, 1989; Paterson et al., 1990) , (Figure 11b ). In contrast, Rac1-mediated induction of SRF was somewhat enhanced by coexpression of RhoA(19N) or C3 (Figure 11b ). Rac1 activation of SRF has been demonstrated to occur independently of RhoA (Hill et al., 1995) . These results show that G2A causes Rho-dependent activation of SRF, although they do not rule out the possibility that a portion of the G2A induced SRF activation is mediated by a Rho-independent process.
Potential mechanisms for signaling from G2A to Rho
The results described above show that G2A expression leads to Rho activation, and that G2A-mediated transformation requires activation of either Ga 12 or Ga 13 . The equivalent alterations induced in the cytoskeleton of PAE cells by G2A and Ga 13 expression, and the complete inhibition by RhoA(19N) of the abilities of G2A and Ga 13 to induce NIH3T3 transformation, indicate that G2A may be activating Ga 13 but not Ga 12 in both these cell types. The ability of Ga 13 to activate Rho on its own suggests a linear relationship of activation from G2A to Ga 13 to Rho. The simplest mechanism for achieving this chain of activation would be for G2A to activate Ga 13 by direct coupling, with Ga 13 then directly activating Lsc, and this exchange factor directly activating Rho. NIH3T3 cells express Lsc, and all lymphoid tissues and cell lines which express G2A also express Lsc , while Rho and Ga 13 are expressed in all cell types (Oermanns and Simon, 1998; Zohn et al., 1998b) . Therefore, the components of this possible pathway are present in the cells used in our studies on G2A signaling, and in the cells which normally express G2A. Rho activation via Ga 13 or Ga 12 in NIH3T3 cells is inhibited by an exchange-defective mutant of Lsc (Mao et al., 1998c) . However, the dominant-negative eect of this Lsc mutant is probably occurring through the GAP activity for Ga 13/12 in its intact RGS domain , as RGS12 has the same eect despite being unrelated to Lsc except in its RGS domain (Mao et al., 1998b,c) . It remains to be determined if the Ga 13 -Lsc pathway is involved in or required for transformation by G2A or any other oncogenic GPCR.
Thrombin receptor and some LPA receptors are also able to activate Rho through Ga 13 and/or Ga 12 (Gohla et al., 1998; Mao et al., 1998b) . There is a dependence on Tec/Bmx kinases or EGF receptor-like kinases for signaling from these and other GPCRs to Rho via Ga 13 or Ga 12 (Gohla et al., 1998 (Gohla et al., , 1999 Mao et al., 1998a) . Intriguingly, Rho activation by Ga 13 but not Ga 12 is blocked by a tyrosine kinase inhibitor or by a dominant negative form of EGF receptor (Gohla et al., 1999; Katoh et al., 1998) . This could re¯ect some form of co-regulation of Lsc by Ga 13 and EGF receptor or another tyrosine kinase, or an Lsc-independent mechanism of Rho activation by Ga 13 .
Other GPCRs activate Rho via mechanisms that are clearly distinct from that used by G2A. The M1-muscarinic acid and a 1 -adrenergic receptors activate Rho exclusively via Ga q (Mao et al., 1998b) . Other GPCRs have the potential to activate Rho as a downstream response to Rac activation. (Mac et al., 1998; Zohn et al., 1998a) . In the case of the formyl peptide receptor, Rac activation requires bg rather than vectors, pcDNA3 ± G2A, pcDNA3 ± Rac1(61L), pcDNA3 ± C3, pAX142 ± RhoA(WT) or pAX142 ± RhoA (19N) . A b-galactosidase expression plasmid was also co-transfected in each case. After serum starving for 16 h, the cells were lysed at 48 h post-transfection and luciferase and b-galactosidase activities were measured. Luciferase activity was normalized to bgalactosidase activity to control for transfection eciency. Data shown are the average of duplicate samples, and are representative of six separate experiments a subunits of G proteins . Some GPCRs that activate Rho appear to be physically complexed with Rho. Rho-complexed receptors are distinguished by having the motif NPxxY in their seventh transmembrane domain, and this motif is required for Rho complex formation (Mitchell et al., 1998) . G2A has the motif DPxxY rather than NPxxY in the seventh transmembrane domain. The aspartate residue has been shown to preclude Rho complex formation in other receptors (Mitchell et al., 1998) , and therefore Rho activation via G2A is unlikely to involve a direct interaction with Rho. This mechanism also seems to be excluded by the ability of LscRGS to suppress G2A-mediated transformation.
It is not known whether the ability of G2A to activate Ga 12/13 is dependent on binding a ligand. This ligand could be present in serum or medium, or could be provided by the same cells that are expressing G2A. Alternatively, high levels of expression of G2A might lead to ligand-independent activation of Ga 12/13 . We have found that retrovirally-transduced thrombin receptor induces transformation of NIH3T3 cells even in the presence of high concentrations of a thrombin inhibitor (R Kay, unpublished), indicating that when Ga 12/13 -coupled receptors are highly expressed they can be active in the absence of what is normally an obligate agonist.
Anti-oncogenic potential of G2A Weng et al. (1998) showed that co-expression of G2A suppressed the ability of the oncogenic tyrosine kinase Bcr-Abl to transform early B cell progenitors, and suppressed the ability of Bcr-Abl to override anchorage dependence in Rat-1 ®broblasts. This group also showed that expression of G2A in NIH3T3 cells caused an accumulation of cells in G2/M following transfer from high to low serum. This was interpreted as re¯ecting its ability to impose a block at this stage of the cell cycle, although an actual arrest of the cell cycle at this stage was not demonstrated. These results implicate G2A as having a proliferation-suppressing role in both ®broblasts and in lymphocytes. Our results clearly show that G2A on its own can override contact inhibition and anchorage dependence in NIH3T3 cells. We also found that NIH3T3 cells expressing G2A could continue to proliferate in low serum, which provides an alternative explanation for the continued presence of G2A-expressing cells with 4N DNA content after transfer from high to low serum (Weng et al., 1998) .
The picture of G2A that emerges from these two independent studies is that this GPCR can provide strong proliferative signals in ®broblasts which reduce growth factor requirements and override the strong inhibition of cell cycle entry that normally is imposed by cell ± cell contact or loss of anchorage. In contrast, co-expression of G2A with Bcr-Abl somehow counteracts the ability of this hyper-activated tyrosine kinase to override cell cycle inhibition in ®broblasts due to loss of anchorage, and also suppresses the ability of Bcr-Abl to promote the outgrowth of pre-B cells from bone marrow progenitors. The suppressive eect of G2A may re¯ect the potential of co-expression of mechanistically distinct oncogenes such as G2A and Bcr-Abl to disrupt cell cycle regulation in a way that leads to growth arrest or apoptosis rather than proliferation.
While G2A is overtly oncogenic in ®broblasts, it is possible that it could play either analogous or contrasting roles in lymphocytes. Both thrombin receptors and LPA receptors are active in lymphocytes, where they can independently provide proliferative signals as well as signals that modulate the responses of lymphocytes to antigen receptor ligation (Joyce et al., 1997; Mari et al., 1994; Maulon et al., 1998; Moolenaar et al., 1997; Tordai et al., 1993) . If G2A is able to activate Rho in lymphocytes, then it has the potential to in¯uence a wide range of cell behaviors, ranging from proliferation and survival to co-stimulation responsiveness, cytotoxicity, adhesion and migration (Kehrl, 1998; Reif and Cantrell, 1998) . The role of G2A in lymphocyte development, selection and activation can now be tested by targetted expression and mutation of the G2A gene in mice and cell lines.
Materials and methods

cDNA library synthesis, viral transmission and screening
The vectors and methodology for the construction of cDNA expression libraries, their conversion to retroviral form, infection of NIH3T3 cells, selection of transformed cell clones, recovery of proviral cDNAs, and secondary screening for transforming cDNA clones have been described previously (Whitehead et al., 1995) . One important modi®cation used in the screen that yielded G2A cDNAs was the use of BOSC 23 packaging cells for production of retroviral libraries, as these cells produce much higher library titers than do the NIH3T3-derived packaging lines that had been used previously (Pear et al., 1993) . To construct the retroviral library, total mRNA isolated from exponentially growing mouse T28 T hybridoma cells was used as the template for cDNA synthesis using random hexamer primers. The cDNAs were ligated into the pCTV1B retrovirus expression vector (Whitehead et al., 1995) . Plasmid DNA was prepared from pooled colonies of the bacterial library and used to transfect BOSC 23 cells. The resulting virus population was used to infect NIH3T3 cells plated at low density. After 2 weeks of culture, foci of transformed cells were picked, and proviral cDNA sequences were recovered by polymerase chain reaction-mediated DNA ampli®cation, using a mixture of Taq polymerase and Pfu polymerase to reduce the frequency of rearrangements and mutations in the PCR-generated products (Barnes, 1994) , and recloned into the pCTV3 retrovirus expression vector (Whitehead et al., 1995) . After conversion to retrovirus, these cDNA clones were tested for transforming activity by infecting NIH3T3 cells. Positive clones were recloned by puri®cation of the cDNA insert and insertion into pCTV3 or related retroviral vectors and retested for transforming activity.
Transfection constructs
G2A transfection constructs were generated by subcloning the SalI fragment from pTL37-5c1 into the BamHI site of the pZIP ± NeoSV(x)1 retrovirus vector (Cepko et al., 1984) , where expression is under the control of the Moloney long terminal repeat (LTR) promoter, or the BamHI site of pCDNA3 ± Neo (Invitrogen), where expression is under the control of the cytomegalovirus promoter. pZIP ± NeoSV(x)1 constructs encoding constitutively activated Ras(61L), Rac1(115I) and RhoA(63L) were described previously (Khosravi-Far et al., 1995) . pCDNA1 expression vectors encoding constitutively activated mutants of Ga 12 , Ga 13 and Ga q were provided by H Bourne (Conklin et al., 1992; Voyno-Yasenetskaya et al., 1994) . pCDNA3-Ga 12 (QL) and pCDNA3-Ga 13 (QL) (Voyno-Yasenetskaya et al., 1994) were constructed by subcloning the EcoRI/XbaI and the BamHI/ XbaI fragments from the respective pCDNA1 constructs into the EcoRI/XbaI and BamHI/XbaI sites of pCDNA3. pZIP ± Ga 12 (QL) and pZIP ± Ga 13 (QL) were constructed by subcloning the EcoRI/XbaI or the BamHI/XbaI fragments from the corresponding pCDNA3 constructs into the BamHI site of pZIP-NeoSV(x)1. pCDNA3 ± Ga q was constructed by subcloning the HindIII fragment from pCMV5D ± Ga 1 (R183C) (Conklin et al., 1992) into the HindIII site of pCDNA3 ± Neo. An expression vector encoding COOH-terminally green uorescent protein (GFP)-tagged G2A was made by fusing the TL37-5c1 coding region upstream of the SstI site (at base 1240) to a GFP construct derived from pEGFPN1 (Invitrogen), expressed within a CTV retroviral vector. This results in the replacement of the last two amino acids of G2A (Leu ± Cys) with GFP.
The RGS domain of Lsc consisted of the ®rst 283 amino acids of Lsc (MGEVAGGAAP . . . NRGEPSAPDC) expressed within a CTV retroviral vector. Murine Lsc is identical to human p115 RhoGEF in 122 of 126 amino acids in the RGS domain, with all four dierences being structurally conservative.
Sequence analysis and comparison
The sequence of cDNA inserts were determined with 373 and 377 ABI DNA Sequencers using FS Taq Dye Terminators (Nucleic Acid-Protein Service Unit, University of British Columbia). Continuous sequence was determined for both strands. Database comparisons were performed with BlastX or BlastP via the National Center for Biotechnology Information website. The sequence similarities of G2A and other sequences was performed with the Best®t and Pileup programs of the Genetics Computer Group (Madison, WI, USA).
Northern blot analyses of G2A transcripts
Total cellular RNA was separated on 5% formaldehyde agarose gels and transferred to Hybond N + nylon membrane (Amersham). Hybridization and high stringency washing were performed as described (Engler-Blum et al., 1993) , using a HincII subfragment predominantly from the 3' untranslated region of the TL37-5c1 cDNA (bases 991 to 1966), labeled with 32 P-ATP by extension of random sequence primers.
Cell culture, transfection and transformation assays T28 cells (Pyszniak et al., 1994) and BOSC-23 retroviral packaging cells (Pear et al., 1993) were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal bovine serum. NIH3T3 cells used for the retroviral screen were obtained from American Type Culture Collection and cultured at low density in DMEM supplemented with 9% calf serum. To determine the frequency of transformation of G2A-expressing cells, NIH3T3 cells were infected with a retrovirus expressing G2A-GFP and plated at very low density. Isolated colonies were scored as being transformed or non-transformed on the basis of morphology and loss of contact inhibition, and the colonies were then isolated, expanded and scored for G2A-GFP expression by¯ow cytometry.
NIH3T3 cells (UNC Strain) and 293T cells were transfected as described previously using the calcium phosphate precipitation technique . For focus formation assays shown in Figure 1 , NIH3T3 cells were transfected and maintained in DMEM supplemented with 10% calf serum for 3 weeks. Cells were stained with 0.4% crystal violet followed by quantitation of transformed foci by visual inspection. Stably transfected cell lines were established by pooling multiple drug-resistant colonies (4100) following selection in growth medium supplemented with 400 mg/ml G418 (Geneticin; GIBCO ± BRL). NIH3T3 cells stably expressing G2A, H-Ras(61L), or RhoA(63L) by transfection were used for the low serum, soft agar and nude mouse tumorigenicity assays using procedures described previously .
For the data shown in Figures 9 and 10 and Tables 1 and  2 , NIH3T3 cells were infected with retroviruses produced by transfection of the BOSC23 ecotropic packaging cell line with derivatives of the CTV3 retroviral vector, carrying resistance for G418 or puromycin. The infection eciency of the cells expressing control virus or dominant negative GTPases was identical as determined by transduction of GFP expression. The cells used for the experiments shown in Figure 10 and Table 2 were generated independently.
The (SRFm) 2 reporter plasmid was used to detect SRF activation (Westwick et al., 1997) . This plasmid contains the luciferase coding region coupled to a minimal c-fos promoter consisting of the serum response element with mutated TCF binding sites. Luciferase assays were performed as previously described (Hauser et al., 1995; Zohn et al., 1998a) , using a Monolight 2010 luminometer.
Analysis of expression of G2A/GFP, and quantification of transformation efficiency NIH3T3 cells infected with a CTV vector encoding G2A/ GFP and a G418-resistance gene were selected in G418, sorted for GFP expression by¯ow cytometry, and then plated at low density and cultured for up to 2 weeks. Colonies that formed were scored visually as being either transformed or non-transformed, then isolated, expanded and tested for GFP expression. To determine the eect of LscRGS on G2A expression and G2A-mediated transformation, NIH3T3 cells singly or doubly infected with CTV vectors expressing G2A/GFP plus G418 resistance and/or LscRGS plus puromycin resistance were selected with G418 and/or puromycin. Some of the cells were then analysed for GFP expression by¯ow cytometry. Other cells were plated at low density and cultured for 8 days. Colonies were scored visually as being either transformed or non-transformed, and the cell cultures were then analysed for GFP expression bȳ ow cytometry.
Immunofluorescence analysis of cytoskeleton organization
As described previously (Khosravi-Far et al., 1994) , stably transfected NIH3T3 cells were plated on glass cover slips and two series of staining were performed. Actin was stained with either tetramethyl rhodamine isothiocyanate (RITC)-phalloidin or¯uorescein isothiocyanate (FITC)-phalloidin (Molecular Probes). The focal adhesion protein vinculin was stained with anti-vinculin monoclonal antibody 7f9 (Glukhova et al., 1990) followed by FITC-conjugated goat anti-mouse immunoglobulin G (Jackson Immunoresearch Laboratories) or RITC-conjugated donkey anti-mouse immunoglobulin G (Chemicon International).
Microinjection and immunofluorescence analyses in PAE cells
Porcine aortic endothelial (PAE) cells were co-injected in the nucleus with pCDNA3 ± G2A, pCDNA3 ± Ga 12 (QL), pCDNA3 ± Ga 13 (QL), pCDNA3 ± Ga q (RC) along with the green lantern plasmid (GIBCO ± BRL) encoding the green uorescent protein (GFP) (25 mg/ml), or Myc epitope-tagged Rac1(12V), CDC42(12V) or RhoA(14V) expression plasmids (50 mg/ml). Growth medium was then switched to serum free medium for 6 h. Cells were ®xed and processed as described previously (Westwick et al., 1997) .
